BRIEF-Voyager Therapeutics Q3 Operating Income USD -26.422 Million
Nov 05 (Reuters) - Voyager Therapeutics Q3 net income USD -24.694 million.
Related stories
Ready Capital Corporation (RC) Targets Breakeven Earnings and Cash Flow
Ready Capital reported third-quarter 2026 results. Management said its priorities are bringing distributable earnings and free cash flow to breakeven and resolving the remaining le
L impact | EARNINGS | Nov 05, 2026, 10:17 PM UTC
Macquarie Reports 50% Jump in First-Half Profit
Macquarie said first-half net profit rose 50%, beating expectations, as commodity-related earnings surged amid increased market volatility.
M impact | EARNINGS | Nov 05, 2026, 10:16 PM UTC
Ready Capital Corporation Reports Third Quarter 2026 Results
NEW YORK, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Ready Capital Corporation (“Ready Capital” or the “Company”) NYSE:RC, a multi-strategy real estate finance company that originates, acqu
L impact | EARNINGS | Nov 05, 2026, 10:16 PM UTC
Imperial Metals 3Q EPS C$0.00 >III.T
L impact | EARNINGS | Nov 05, 2026, 10:15 PM UTC
Comstock Holding 3Q EPS 6c >CHCI
L impact | EARNINGS | Nov 05, 2026, 10:15 PM UTC
Pembina Pipeline Reports Third-Quarter Adjusted EPS
M impact | EARNINGS | Nov 05, 2026, 10:14 PM UTC